Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

Alexandra D Dreyfuss1,2, Joachim Yahalom3, Sridevi Rajeeve4

  • 1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. adreyfuss@miami.edu.

Blood Cancer Journal
|August 19, 2026
PubMed
Abstract

No abstract available in PubMed .